Impact of molecular point-of-care testing on surveillance and public health management of invasive meningococcal disease
Although the number of IMD cases confirmed solely by POCT remains low, use of POCT is increasing. The impact on IMD surveillance, strain characterization and public health response must be carefully monitored to ensure that case management, outbreak detection and national disease trends are not adversely affected.
Authors
- Emma J. Heymer (ORCID: https://orcid.org/0000-0001-5115-0293)
- Sonia Ribeiro (ORCID: https://orcid.org/0000-0002-9641-4392)
- S. A. Clark (ORCID: https://orcid.org/0000-0002-4916-3623)
- Shamez Ladhani (ORCID: https://orcid.org/0000-0002-0856-2476)
- Xilian Bai (ORCID: https://orcid.org/0000-0001-7560-8094)
- Ray Borrow (ORCID: https://orcid.org/0000-0002-0691-6568)
- Helen Campbell (ORCID: https://orcid.org/0000-0001-9840-8917)
- Andrew Fox (ORCID: https://orcid.org/0000-0001-7400-3819)
- Jay Lucidarme (ORCID: https://orcid.org/0000-0001-5553-2512)
Institutions
- National Health Service (GB)
- National Security Agency (US)
- Department of Health and Social Care (GB)
- St George's, University of London (GB)
- Manchester Royal Infirmary (GB)
- Merseytravel (GB)
- UK Health Security Agency (GB)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1016/j.ijid.2025.108187
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.00